Patrick Brown, MD, graduated from Medical University of South Carolina College of Medicine, Charleston, SC, in 1998 and completed his residency in pediatrics at the Johns Hopkins University School of Medicine, Baltimore, MD, in 200. Prof. Brown then completed a fellowship in pediatric oncology at the Johns Hopkins University School of Medicine in 2004, where he currently works as the Director of the Pediatric Leukemia Program and Professor of Oncology.
Speaking on novel therapies for childhood leukemias
Prof. Brown is an expert in the field of childhood blood cancers, with a particular interest in developing new therapies to improve cure rate for children with leukemia. His research lab investigates the FLT3 gene and associated targeted therapies. As a member of the Johns Hopkins Kimmel Cancer Center, Prof. Brown lead the first clinical trial of an FLT3 inhibitor combined with chemotherapy for children with leukemia.